publication date: Dec. 11, 2015

Rodriguez-Galindo to Lead St. Jude International Outreach 


CARLOS RODRIGUEZ-GALINDO joined St. Jude Children’s Research Hospital to head the International Outreach Program.

Rodriguez-Galindo will also serve as an executive vice president, and will chair the newly created Department of Global Pediatric Medicine, as well as hold the Four Stars of Chicago Endowed Chair in International Pediatric Research.

A native of Spain, Rodriguez-Galindo came to St. Jude in 1994 as a postdoctoral fellow and served as a clinical researcher and faculty member for more than a decade. His work focused on therapies for retinoblastoma, sarcomas and rare childhood cancers.

He returns to St. Jude from Dana-Farber Cancer Institute and Boston Children’s Hospital, where he was director of the Pediatric Solid Tumor Program, medical director of the Clinical and Translational Investigations Program, and director of the Global Health Initiative in Pediatric Cancer and Blood Disorders. He also served as professor of Pediatrics at Harvard Medical School.

The International Outreach Program has helped create networks such as the Asociación de Hemato-Oncología Pediátrica de Centro América, which includes members from Guatemala, Honduras, El Salvador, Nicaragua, Costa Rica, Dominican Republic and Panama; the National Childhood ALL Study Group in China; and the Pediatric Oncology East and Mediterranean Group, which encompasses partner sites and collaborating centers in more than 20 countries in the Middle East, northern Africa and southern Asia.


DANIEL SIMON was named president of University Hospitals Case Medical Center, effective Jan. 1, 2016.

Simon will … Continue reading 41-45 Rodriguez-Galindo to Lead St. Jude International Outreach

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.